Although higher PD‐L1 expression is typically considered favorable for anti‐PD‐L1and anti‐PD‐1 treatment responses, our review of clinical imaging reports from HCC patients treated with anti‐PD‐1 revealed that high PD‐L1 expression does not consistently predict strong immune responses. The gene discussed is CD274; the disease is hepatocellular carcinoma.